Warning: Use of undefined constant KT_BSEO - assumed 'KT_BSEO' (this will throw an Error in a future version of PHP) in /homepages/46/d347802020/htdocs/los-angeles-dentist-blog/wp-content/plugins/keyword-tag-wrapper/keyword-tagger-bseo.php on line 10

Warning: Use of undefined constant KT_BSEO_DB_VERSION - assumed 'KT_BSEO_DB_VERSION' (this will throw an Error in a future version of PHP) in /homepages/46/d347802020/htdocs/los-angeles-dentist-blog/wp-content/plugins/keyword-tag-wrapper/keyword-tagger-bseo.php on line 11

Warning: Use of undefined constant wp_cumulus_widget - assumed 'wp_cumulus_widget' (this will throw an Error in a future version of PHP) in /homepages/46/d347802020/htdocs/los-angeles-dentist-blog/wp-content/plugins/wp-cumulus/wp-cumulus.php on line 375
Urine test improves prediction of high-grade prostate cancer | Dentist Beverly Hills, Dentist Los Angeles
Dentist Los Angeles | Dentist Beverly Hills | General Dentist | Cosmetic Dentist | Dental Implant | Dental Office



Urine exam improves prophecy of high-grade prostate cancer

Posted by Z Dental Group - March 31st, 2016

NEW YORK, NY (March 31, 2016)–An initial urine examination that detects genetic changes compared with prostate cancer identified 92 percent of group with towering PSA (prostate-specific antigen) levels who had high-grade cancers, according to a investigate published currently in JAMA Oncology online.

“The examination has a intensity to be a poignant alleviation over PSA alone in specifying between low- and high-grade prostate cancer, generally in a PSA gray section patient. It could revoke hundreds of thousands of invasive biopsies any year. Given a pain and risks compared with behaving a prostate biopsy, that’s not a pardonable thing,” pronounced initial author James McKiernan, MD, a John K. Lattimer Professor and chair of urology during Columbia University Medical Center (CUMC) and urologist-in-chief during NewYork-Presbyterian/Columbia. In addition, a examination is a usually urine-based examination that does not need a digital rectal examination before to collection and is simply integrated in a hospital environment.

Although a PSA blood examination is ordinarily used to shade for prostate cancer, a value has come underneath question. An towering PSA level–above 4 ng/mL–only indicates that a studious might have cancer and does not reliably heed between low-grade cancer, that can be monitored though active treatment, and high-grade disease, that requires assertive diagnosis with medicine or deviation therapy. And, since PSA tests produce a high series of fake certain results–only 25 percent of group with an towering PSA turn have prostate cancer–the US Preventive Services Task Force recommends opposite PSA-based screening.

The usually approach to definitively diagnose prostate cancer is with a hankie biopsy, a unpleasant procession that carries a estimable risk of draining and infection and a really tiny possibility of death.

“Consequently, group with high PSA levels are typically suggested to have a biopsy, even yet many have no cancer during all, or have a form of illness that can be monitored though treatment,” pronounced Dr. McKiernan. “In other words, a lot of group are undergoing nonessential biopsies.”

In a study, prostate biopsy formula from 774 group with PSA levels between 2 and 10 were compared with a combination magnitude formed on formula of a urine examination and other risk factors, including PSA level, age, race, and family story of a disease.

Using information from 255 of a men, a researchers initial set a cut-off magnitude of 15.6 that identified over 90 percent of group found to have high-grade cancer. The researchers afterwards assessed a test’s opening among a remaining 519 group regulating a designated cut-off score. A magnitude above 15.6 was used to envision a participation of high-grade cancer (Gleason Score larger or equal to 7); a magnitude equal to or next 15.6 was used to envision a participation of low-grade cancer or no disease.

This investigate showed that a examination rightly identified 92 percent of group with high-grade cancer. However, a examination also expected high-grade cancer in 66 percent of group whose biopsies suggested low-grade or no cancer. In clinical practice, use of a examination would have spared 27 percent of group from carrying an nonessential prostate biopsy.

Among a 138 group who perceived a low examination score, presaging low-grade or no cancer, 91 percent had no cancer or low-grade cancer that didn’t need evident treatment. “By adding this examination to a evaluation, group who accept a low magnitude could potentially select to abandon a biopsy,” Dr. McKiernan says.

Of a 12 group who had high-grade cancer though perceived a low examination score, 9 had tolerably assertive cancer that would expected have been rescued with follow-up monitoring. The remaining 3 had a aloft risk of cancer.

The test, called ExoDxTM Prostate(IntelliScore), detects RNA from 3 genes (ERG, PCA3, and SPDEF) that have been related to a growth and course of prostate cancer. The RNA is encapsulated in lipid membrane-coated structures called exosomes that are excreted by cancer cells into urine. The test, grown by Exosome Diagnostics of Cambridge, MA, is a initial urine-based examination for prostate cancer that does not need a digital rectal examination or prostate massage before representation collection. Additional clinical trials to obtain FDA capitulation are being planned.

Based on a stream study, a test’s AUROC score, that is a magnitude of how good a examination and PSA and risk factors distinguishes group with high-grade illness from group without, was higher to that of a stream customary of care, during 0.72 contra 0.63. (A examination with an AUROC magnitude of 1.0 is perfect; a examination that performs no improved than pointless guessing has a magnitude of 0.5.)

Prostate cancer is a many common plain turpitude and a second heading means of cancer genocide in group worldwide, with over a million new cases and approximately 300,000 deaths in 2014, according to a researchers. Approximately dual million transrectal ultrasound-guided prostate biopsies are achieved any year in a US and Europe.


The investigate is titled, “A Novel Urine Exosome Gene Expression Assay Predicts High-Grade Prostate Cancer during Initial Biopsy.” The other contributors are: Michael J. Donovan, PhD, MD, (Icahn School of Medicine during Mt. Sinai, NY); Vince O’Neill, MD, Stefan Bentink, PhD, Mikkel Noerholm, MS, Susan Belzer, and Johan Skog, PhD (Exosome Diagnostics, Cambridge, MA); Michael W. Kattan, PhD (Cleveland Clinic, Cleveland, OH), Alan Partin, MD (Johns Hopkins University School of Medicine, Baltimore, MD), Gerald Andriole, MD, PhD (Washington University School of Medicine in St. Louis, MO), Gordon Brown, MD (Delaware Valley Urology, Voorhees, NJ), John T. Wei, MD (University of Michigan, Ann Arbor, MI), Ian M. Thompson, Jr, MD (University of Texas Health Science Center during San Antonio, TX), and Peter Carroll, MD (University of California, San Francisco, CA).

The investigate was upheld by grants from Exosome Diagnostics.

The following authors (M. Noerholm, S. Bentink, S. Belzer, J. Skog, V. O’Neill) are employees of Exosome Diagnostics, Inc. Michael J. Donovan and Michael W. Kattan are consultants to Exosome Diagnostics. The authors news no other conflicts of interest.

Columbia University Medical Center provides general caring in basic, preclinical, and clinical research; medical and health sciences education; and studious care. The medical core trains destiny leaders and includes a dedicated work of many physicians, scientists, open health professionals, dentists, and nurses during a College of Physicians and Surgeons, a Mailman School of Public Health, a College of Dental Medicine, a School of Nursing, a biomedical departments of a Graduate School of Arts and Sciences, and associated investigate centers and institutions. Columbia University Medical Center is home to a largest medical investigate craving in New York City and State and one of a largest expertise medical practices in a Northeast. For some-more information, revisit cumc.columbia.edu or columbiadoctors.org.


NewYork-Presbyterian is one of a nation’s many extensive medical smoothness networks, focused on providing innovative and merciful caring to patients in a New York civil area and via a globe. In partnership with dual eminent medical propagandize partners, Weill Cornell Medicine and Columbia University College of Physicians Surgeons, NewYork-Presbyterian is consistently famous as a personality in medical education, groundbreaking investigate and clinical innovation.

NewYork-Presbyterian has 4 vital divisions: NewYork-Presbyterian Hospital is ranked #1 in a New York civil area by U.S. News and World Report and regularly named to a magazine’s Honor Roll of best hospitals in a nation; NewYork-Presbyterian Regional Hospital Network is comprised of heading hospitals in and around New York and delivers high-quality caring to patients via a region; NewYork-Presbyterian Physician Services connects medical experts with patients in their communities; and NewYork-Presbyterian Community and Population Health facilities a hospital’s ambulatory caring network sites and operations, village caring initiatives and medical peculiarity programs, including NewYork Quality Care, determined by NewYork-Presbyterian, Weill Cornell and Columbia.

NewYork-Presbyterian is one of a largest medical providers in a U.S. Each year, scarcely 29,000 NewYork-Presbyterian professionals broach well-developed caring to some-more than 2 million patients.

For some-more information, revisit www.nyp.org and find us on Facebook, Twitter and YouTube.

Shared Post

    Tags: ,

    Leave a Reply

    You must be logged in to post a comment.

    Blog Home